EPISODE · Sep 3, 2019 · 8 MIN
Biostage, Inc. Joins the Stock Day Podcast to Discuss Their Pending FDA Application
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Jim McGorry of Biostage, Inc. (BSTG) (“the Company”), a biotechnology startup developing bioengineered organ implants based on its Cellspan technology that combines a proprietary biocompatible scaffold with a patient's own stem cells to create bioengineered organ implants. McGorry is the Company CEO and director, and was joined by Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
The Stock Day Podcast welcomed Jim McGorry of Biostage, Inc. (BSTG) (“the Company”), a biotechnology startup developing bioengineered organ implants based on its Cellspan technology that combines a proprietary biocompatible scaffold with a patient's own stem cells to create bioengineered organ implants. McGorry is the Company CEO and director, and was joined by Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
Biostage, Inc. Joins the Stock Day Podcast to Discuss Their Pending FDA Application
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m